Breaking News Instant updates and real-time market news.

PTON

Peloton

$30.22

2.94 (10.78%)

07:34
11/19/19
11/19
07:34
11/19/19
07:34

JPMorgan reiterates Overweight rating on Peloton after management meetings

After hosting investor meetings with management, JPMorgan analyst Doug Anmuth reiterates an Overweight rating on Peloton with a $34 price target. The company has "multiple near-term drivers," including the Bike Home Trial, new marketing for 0% financing, new 0% Tread financing for three years, and this week's launch in Germany, Europe's largest fitness market, Anmuth tells investors in a research note. The analyst continues to believe Peloton is well positioned to disrupt the fitness industry and he sees "significant runway for profitable growth."

  • 09

    Dec

PTON Peloton
$30.22

2.94 (10.78%)

10/24/19
10/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Peloton (PTON) initiated with an Outperform at Bernstein. 2. Lyft (LYFT) initiated with an Equal Weight at Morgan Stanley. 3. Nektar (NKTR) initiated with a Perform at Oppenheimer. 4. Kellogg (K) initiated with an In Line at Evercore ISI. 5. Pitney Bowes (PBI) initiated with a Buy at National Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/19
BARD
11/06/19
NO CHANGE
Target $29
BARD
Outperform
Peloton weakness a buying opportunity, says Baird
Baird analyst Jonathan Komp continues to recommend the purchase of Peloton shares and views the recent moderate weakness as a buying opportunity. He said he was highly encouraged by its first public company report which featured much better than expected revenue and reduced losses. He believes forward assumptions are conservative given the company's strong brand/product momentum. Komp reiterated his Outperform rating and raised his price target to $29 from $28 on Peloton shares.
11/06/19
LEHM
11/06/19
NO CHANGE
Target $33
LEHM
Overweight
Barclays does not see Peloton rally despite 'very encouraging' Q1
Peloton Interactive's "solid" fiscal Q1 results are "very encouraging," but the stock is unlikely to be "rewarded meaningfully," Barclays analyst Deepak Mathivanan tells investors in a post-earnings research note. Sentiment around loss-making initial public offerings with upcoming lock-up expirations "remains sour," and Peloton is likely to be lumped into a similar bucket near-term, says the analyst. With that said, Mathivanan remains bullish on the secular trends in connected fitness and Peloton's long-term competitive position. He raised his price target to $33 from $32 and keeps an Overweight rating on the shares.
11/14/19
BERN
11/14/19
NO CHANGE
Target $29
BERN
Outperform
Lower priced Peloton treadmill could generate higher sales, says Bernstein
Bernstein analyst Jamie Merriman tells investors in a research note that given the high price point of Peloton's connected treadmill Tread, she forecasts limited sales volumes over the next five years, expecting cumulative sales of ~500K compared to ~3.3M bikes additional bikes sold by 2024. However, a lower priced treadmill could generate higher sales dollars, Merriman says. She keeps an Outperform rating and $29 price target on the shares.

TODAY'S FREE FLY STORIES

AEP

American Electric

$91.94

0.045 (0.05%)

14:23
12/10/19
12/10
14:23
12/10/19
14:23
Hot Stocks
PSO reaches settlement pact with Public Utility Division Staff of OCC »

Public Service Company of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CORV

Correvio

$1.39

(0.00%)

14:22
12/10/19
12/10
14:22
12/10/19
14:22
Periodicals
FDA panel said to vote against recommending approval for Correvio's Brinavess »

SAC Tracker, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

14:20
12/10/19
12/10
14:20
12/10/19
14:20
General news
The Europe Brief: »

The Europe Brief:…

EVH

Evolent Health

$9.02

1.125 (14.25%)

14:17
12/10/19
12/10
14:17
12/10/19
14:17
Recommendations
Evolent Health analyst commentary  »

William Blair says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/10/19
12/10
14:17
12/10/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/10/19
12/10
14:16
12/10/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$14.09

-6.42 (-31.30%)

14:03
12/10/19
12/10
14:03
12/10/19
14:03
Downgrade
Conn's rating change  »

Conn's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

CONN

Conn's

$14.08

-6.43 (-31.35%)

13:59
12/10/19
12/10
13:59
12/10/19
13:59
Downgrade
Conn's rating change  »

Conn's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

EVH

Evolent Health

$8.46

0.565 (7.16%)

13:59
12/10/19
12/10
13:59
12/10/19
13:59
Periodicals
Kentucky committee rejects outgoing governor's 'snub' of Evolent, LBF says »

The Government Contract…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$47.78

-0.11 (-0.23%)

13:56
12/10/19
12/10
13:56
12/10/19
13:56
Conference/Events
UDR, Inc. management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

XOM

Exxon Mobil

$68.73

-0.93 (-1.34%)

13:54
12/10/19
12/10
13:54
12/10/19
13:54
Hot Stocks
Exxon: Ruling affirms position company has held throughout 'baseless' probe »

ExxonMobil issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ADPT

Adaptive Biotechnologies

$29.09

-0.21 (-0.72%)

13:54
12/10/19
12/10
13:54
12/10/19
13:54
Conference/Events
Adaptive Biotechnologies management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVGO

Livongo Health

$25.83

-1.57 (-5.73%)

13:52
12/10/19
12/10
13:52
12/10/19
13:52
Recommendations
Livongo Health analyst commentary  »

Livongo Health valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

WDFC

WD-40

$194.62

-1.12 (-0.57%)

13:51
12/10/19
12/10
13:51
12/10/19
13:51
Hot Stocks
WD-40 increases quarterly dividend nearly 10% »

WD-40 Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

13:50
12/10/19
12/10
13:50
12/10/19
13:50
General news
Treasury Action: the Treasury market is unmoved »

Treasury Action: the…

13:49
12/10/19
12/10
13:49
12/10/19
13:49
Conference/Events
JPMorgan consumer finance analyst to hold analyst/industry conference call »

Specialty & Consumer…

EVH

Evolent Health

$8.27

0.375 (4.75%)

13:49
12/10/19
12/10
13:49
12/10/19
13:49
Hot Stocks
Evolent Health jumps $1.55, or 20%, to $9.42 »

Contacts tell The Fly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
12/10/19
12/10
13:45
12/10/19
13:45
Conference/Events
JPMorgan semiconductors anayst to hold an analyst/industry conference call »

Semiconductors,…

NFLX

Netflix

$297.38

-5.1 (-1.69%)

13:45
12/10/19
12/10
13:45
12/10/19
13:45
Hot Stocks
Netflix says 'really proud' of animation work, cadence of films picking up »

Speaking at the UBS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

13:41
12/10/19
12/10
13:41
12/10/19
13:41
Conference/Events
JPMorgan restaurants analyst to hold an analyst/industry conference call »

Restaurants Analyst…

VALE

Vale

$12.35

-0.035 (-0.28%)

13:33
12/10/19
12/10
13:33
12/10/19
13:33
Conference/Events
Morgan Stanley materials analyst holds an analyst/industry conference call »

Head of Australia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$14.24

0.075 (0.53%)

13:33
12/10/19
12/10
13:33
12/10/19
13:33
Hot Stocks
CenturyLink pays Washington $6.1M to settle hidden fees lawsuit »

Washington Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CI

Cigna

$190.30

-5.59 (-2.85%)

, MET

MetLife

$49.25

-0.315 (-0.64%)

13:31
12/10/19
12/10
13:31
12/10/19
13:31
Periodicals
New York Life in talks to buy nonmedical insurance unit from Cigna, WSJ reports »

New York Life Insurance…

CI

Cigna

$190.30

-5.59 (-2.85%)

MET

MetLife

$49.25

-0.315 (-0.64%)

SLF

Sun Life Financial

$44.95

0.465 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Feb

  • 13

    Feb

UPWK

Upwork

$10.60

-0.55 (-4.93%)

13:25
12/10/19
12/10
13:25
12/10/19
13:25
Options
Upwork call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

VIAC

ViacomCBS

$38.13

-0.52 (-1.35%)

, VIACA

ViacomCBS

$41.51

-0.27 (-0.65%)

13:23
12/10/19
12/10
13:23
12/10/19
13:23
Periodicals
ViacomCBS, Paramount resume talks to buy Miramax stake, Variety reports »

ViacomCBS and Paramount…

VIAC

ViacomCBS

$38.13

-0.52 (-1.35%)

VIACA

ViacomCBS

$41.51

-0.27 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.